Hepatitis C, stigma and cure

被引:72
作者
Marinho, Rui Tato [1 ]
Barreira, David Pires [1 ]
机构
[1] Hosp Santa Maria, Dept Gastroenterol & Hepatol, Med Sch Lisbon, P-1649035 Lisbon, Portugal
关键词
Hepatitis C; Chronic; Therapy; Hepatocellular carcinoma; Hepatic cirrhosis; Interferon-alpha; Ribavirin; Social stigma; Depression; QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; NATURAL-HISTORY; INTERFERON-ALPHA; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL THERAPY; SPLENIC LYMPHOMA; VIRUS-INFECTION; NON-A; DEPRESSION;
D O I
10.3748/wjg.v19.i40.6703
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The infection with hepatitis C virus (HCV) is one of the most important global chronic viral infections worldwide. It is estimated to affect around 3% of the world population, about 170-200 million people. Great part of the infections are asymptomatic, the patient can be a chronic carrier for decades without knowing it. The most severe consequences of the chronic infection are liver cirrhosis and hepatocellular carcinoma, which appears in 20%-40% of the patients, leading to hepatic failure and death. The HCV was discovered 25 years ago in 1989, is a RNA virus and classified by the World Health Organization as an oncogenic one. Hepatocellular carcinoma is one of the most important cancers, the fifth worldwide in terms of mortality. It has been increasing in the Ocidental world, mainly due to chronic hepatitis C. Hepatitis C is not only a liver disease and a cause of cirrhosis, but also a mental, psychological, familiar, and social disease. The stigma that the infected person sometimes carries is tremendous having multiple consequences. The main cause is lack of adequate information, even in the health professionals setting. But, besides the "drama" of being infected, health professionals, family, society and the infected patients, must be aware of the chance of real cure and total and definitive elimination of the virus. The treatment for hepatitis C has begun in the last 80's with a percentage of cure of 6%. Step by step the efficacy of the therapy for hepatitis C is rapidly increasing and nowadays with the very new medications, the so called Direct Antiviral Agents-DAAs of new generation, is around 80%-90%. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:6703 / 6709
页数:7
相关论文
共 65 条
  • [1] Almasio Piero Luigi, 2007, Dig Liver Dis, V39 Suppl 1, pS88, DOI 10.1016/S1590-8658(07)80018-1
  • [2] Epidemiology of hepatitis C virus infection
    Alter, Miriam J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) : 2436 - 2441
  • [3] Alvarez F, 1996, CLIN INVEST MED, V19, P381
  • [4] Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients
    Angelino, AF
    Treisman, GJ
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2006, 17 (06) : 471 - 476
  • [5] *ANT DISCR BOARD N, 2001, REP INQ HEP C REL DI
  • [6] Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications
    Benvegnù, L
    Gios, M
    Boccato, S
    Alberti, A
    [J]. GUT, 2004, 53 (05) : 744 - 749
  • [7] HIV-related stigma among people with HIV and their families: A qualitative analysis
    Bogart, Laura M.
    Cowgill, Burton O.
    Kennedy, David
    Ryan, Gery
    Murphy, Debra A.
    Elijah, Jacinta
    Schuster, Mark A.
    [J]. AIDS AND BEHAVIOR, 2008, 12 (02) : 244 - 254
  • [8] Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
    Bolondi, L
    Sofia, S
    Siringo, S
    Gaiani, S
    Casali, A
    Zironi, G
    Piscaglia, F
    Gramantieri, L
    Zanetti, M
    Sherman, M
    [J]. GUT, 2001, 48 (02) : 251 - 259
  • [9] Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort
    Braitstein, P
    Montessori, V
    Chan, K
    Montaner, JSG
    Schechter, MT
    O'Shaughnessy, MV
    Hogg, RS
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2005, 17 (04): : 505 - 515
  • [10] Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study
    Bruno, Savino
    Crosignani, Andrea
    Facciotto, Corinna
    Rossi, Sonia
    Roffi, Luigi
    Redaelli, Alessandro
    de Franchis, Roberto
    Almasio, Piero Luigi
    Maisonneuve, Patrick
    [J]. HEPATOLOGY, 2010, 51 (06) : 2069 - 2076